Table C.2. Clinical characteristics of patient No.2.

Pt*	Duration of symptoms (days)	Etiology/ Diagnosis/ Pathogen	ATB treatment (inpatient)/ (outpatient)	Scintigraphy (interval and result)	Type of scintigraphy imaging	Outcome
* Pt (patient).
2	639	external otitis/ central skull base osteomyelitis/ Ps. aeruginosa	Ceftazidime (2000 mg/day) + Ciprofloxacin(800 mg/day) (parenteral therapy)	1. at diagnosis, positive	diagnostic
			Clindamycin (900 mg/day) + Ciprofloxacin (1000 mg/day) (oral therapy)	2. after 6 weeks, positive (slight decrease in uptake)	monitor treatment response
			Piperacillin/tazobactam (13,5gr/day) + Sulfamethoxazole/trimethoprim (1600/320 mg/day) (parenteral therapy)	3. after 6 weeks, positive (increase in uptake)
			note: therapy discontinuation (prevention of full development of adverse reactions)	4. after 13.5 weeks, positive (slight decrease in uptake)
				5. after 40 weeks, negative		cured
				6. after 42 weeks, negative	follow-up	non-recurrence